Allergan (AGN) Coveraged By Stifel Nicolaus with $192 Target; AMAZON.COM (AMZN) SI Decreased By 17.43%

April 17, 2018 - By Louis Casey

Allergan plc (NYSE:AGN) Logo

Equity analysts at Stifel Nicolaus has started coverage on Allergan (NYSE:AGN) with a Hold rating. The TP for AGN is exactly $192. It means a potential upside of 15.35% from company’s stock close price.

AMAZON.COM Inc (NASDAQ:AMZN) had a decrease of 17.43% in short interest. AMZN’s SI was 4.05 million shares in April as released by FINRA. Its down 17.43% from 4.91M shares previously. With 7.46 million avg volume, 1 days are for AMAZON.COM Inc (NASDAQ:AMZN)’s short sellers to cover AMZN’s short positions. The SI to AMAZON.COM Inc’s float is 1.01%. The stock increased 0.75% or $10.71 during the last trading session, reaching $1441.5. About 2.63M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 76.78% since April 17, 2017 and is uptrending. It has outperformed by 65.23% the S&P500.

Investors sentiment increased to 1.25 in 2017 Q4. Its up 0.92, from 0.33 in 2017Q3. It improved, as 2 investors sold Allergan plc shares while 2 reduced holdings. 1 funds opened positions while 4 raised stakes. 44,210 shares or 18.56% less from 54,287 shares in 2017Q3 were reported. Eqis Cap Management Inc has invested 0.09% of its portfolio in Allergan plc (NYSE:AGN). Amer & reported 33 shares. Mitchell Mcleod Pugh Williams accumulated 3,965 shares. 214 were accumulated by Gemmer Asset Management Limited Liability Company. Callahan Advsr Ltd Liability stated it has 0.15% of its portfolio in Allergan plc (NYSE:AGN). Frontier Inv Co accumulated 14,953 shares. Cubic Asset Mngmt Ltd Company has 0.11% invested in Allergan plc (NYSE:AGN). Grassi Investment Mngmt reported 7,435 shares stake.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The company has market cap of $54.53 billion. It operates through US Specialized Therapeutics, US General Medicine, and International divisions. It currently has negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, womenÂ’s health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as AlzheimerÂ’s disease.

The stock increased 1.27% or $2.08 during the last trading session, reaching $166.45. About 1.79M shares traded. Allergan plc (NYSE:AGN) has declined 33.03% since April 17, 2017 and is downtrending. It has underperformed by 44.58% the S&P500.

Analysts await Allergan plc (NYSE:AGN) to report earnings on April, 30 before the open. They expect $3.36 earnings per share, up 0.30% or $0.01 from last year’s $3.35 per share. AGN’s profit will be $1.10 billion for 12.38 P/E if the $3.36 EPS becomes a reality. After $4.86 actual earnings per share reported by Allergan plc for the previous quarter, Wall Street now forecasts -30.86% negative EPS growth.

Among 28 analysts covering Allergan Inc. (NYSE:AGN), 20 have Buy rating, 0 Sell and 8 Hold. Therefore 71% are positive. Allergan Inc. has $400 highest and $171.0 lowest target. $250.52’s average target is 50.51% above currents $166.45 stock price. Allergan Inc. had 113 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Allergan plc (NYSE:AGN) earned “Hold” rating by Piper Jaffray on Thursday, August 3. The firm earned “Neutral” rating on Monday, April 18 by Guggenheim. The stock of Allergan plc (NYSE:AGN) earned “Buy” rating by Leerink Swann on Monday, September 21. On Thursday, November 3 the stock rating was maintained by Morgan Stanley with “Overweight”. The stock has “Hold” rating by Piper Jaffray on Friday, July 14. Cantor Fitzgerald maintained the shares of AGN in report on Tuesday, July 18 with “Hold” rating. Goldman Sachs downgraded the shares of AGN in report on Wednesday, May 10 to “Neutral” rating. The rating was maintained by Leerink Swann on Wednesday, October 28 with “Outperform”. The firm has “Buy” rating by Cowen & Co given on Tuesday, October 10. Canaccord Genuity maintained it with “Buy” rating and $396 target in Sunday, August 9 report.

Among 54 analysts covering Amazon.com (NASDAQ:AMZN), 50 have Buy rating, 0 Sell and 4 Hold. Therefore 93% are positive. Amazon.com had 283 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, February 2 by Mizuho. Piper Jaffray maintained Amazon.com, Inc. (NASDAQ:AMZN) rating on Tuesday, April 10. Piper Jaffray has “Buy” rating and $165000 target. The company was maintained on Friday, October 28 by RBC Capital Markets. The firm has “Overweight” rating by Piper Jaffray given on Tuesday, January 3. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Overweight” rating given on Friday, October 23 by Piper Jaffray. The company was maintained on Thursday, July 20 by Morgan Stanley. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by Piper Jaffray on Wednesday, March 14. Robert W. Baird maintained it with “Buy” rating and $1100.0 target in Monday, September 11 report. UBS maintained the shares of AMZN in report on Friday, July 29 with “Buy” rating. The rating was maintained by Needham on Tuesday, January 30 with “Buy”.

Investors sentiment increased to 1.29 in Q4 2017. Its up 0.03, from 1.26 in 2017Q3. It increased, as 69 investors sold Amazon.com, Inc. shares while 578 reduced holdings. 168 funds opened positions while 667 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. British Columbia Investment Mngmt Corporation holds 194,296 shares. Brown Brothers Harriman & invested 0.02% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Asset Mgmt Inc has invested 1.36% in Amazon.com, Inc. (NASDAQ:AMZN). Aldebaran Financial invested in 2.91% or 3,747 shares. Brown Advisory Secs Ltd has 3.06% invested in Amazon.com, Inc. (NASDAQ:AMZN) for 13,569 shares. Evermay Wealth Limited Liability Company holds 1.26% or 2,937 shares. The California-based David R Rahn & Incorporated has invested 2.95% in Amazon.com, Inc. (NASDAQ:AMZN). Boston Private Wealth Ltd holds 26,378 shares or 1.16% of its portfolio. Bb&T owns 23,996 shares. Moore Management L P accumulated 90,500 shares. Moreover, Arrow Financial has 2.79% invested in Amazon.com, Inc. (NASDAQ:AMZN) for 10,320 shares. Glenview Fincl Bank Dept owns 230 shares. 1832 Asset Lp reported 146,512 shares. Clarivest Asset Mngmt Ltd Co has 126,364 shares. Harbour Inv Management Ltd Liability Com has invested 2.05% in Amazon.com, Inc. (NASDAQ:AMZN).

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: